Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Goodwill (2023 - 2024)

Historic Goodwill for Neurocrine Biosciences (NBIX) over the last 2 years, with Q4 2024 value amounting to $5.7 million.

  • Neurocrine Biosciences' Goodwill fell 172.41% to $5.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.7 million, marking a year-over-year decrease of 172.41%. This contributed to the annual value of $5.7 million for FY2024, which is 172.41% down from last year.
  • According to the latest figures from Q4 2024, Neurocrine Biosciences' Goodwill is $5.7 million, which was down 172.41% from $6.1 million recorded in Q3 2024.
  • In the past 5 years, Neurocrine Biosciences' Goodwill registered a high of $6.1 million during Q3 2024, and its lowest value of $5.5 million during Q3 2023.